Fig. 3From: A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquineArithmetic mean (SD) plasma concentration time profiles for piperaquine according to time and treatment group. Inset, first 24 h after dosing. Solid lines with open circles represent the PPQ concentrations when given as monotherapy and dashed lines with cross marks represent PPQ concentrations when given in combination with KAF156Back to article page